Skip to main content

Table 5 Complications, underlying conditions and disease severity parameters among various etiological groups

From: Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia

Characteristic

MP (n = 68)

Mp-Vir (n = 30)

P

Mp-HRV (n = 20)

P

Mp-Vir (excluding HRV) (n = 10)

P

Mp-Bac (n = 7)

P

Complicationsa

 Any condition (≥1 condition)

55 (80.88)

29 (96.67)

0.081

20 (100)

0.078

9 (90)

0.795

7 (100)

0.454

 Pleural effusion

35 (51.47)

13 (43.33)

0.458

6 (30)

0.091

7 (70)

0.449

5 (71.43)

0.542

  Small

1 (1.47)

1 (3.33)

0.144

1 (5)

0.092

0 (0)

0.433

2 (28.57)

0.073

  Moderate

33 (48.53)

10 (33.33)

 

4 (20)

 

6 (60)

 

3 (42.86)

 

  Massive

1 (1.47)

2 (6.67)

 

1 (5)

 

1 (10)

 

0 (0)

 

 Consolidation

37 (54.41)

20 (66.67)

0.257

13 (65)

0.401

7 (70)

0.557

7 (100)

0.054

  Lobar or unilateral change

34 (50)

17 (56.67)

0.721

11 (55)

0.83

6 (60)

0.513

6 (85.71)

0.513

  Bilateral pulmonary multiple change

3 (4.41)

3 (10)

 

2 (10)

 

1 (10)

 

1 (14.29)

 

 Pulmonary atelectasis

7 (10.29)

5 (16.67)

0.581

5 (25)

0.189

0 (0)

0.586

2 (28.57)

0.196

 Liver dysfunction

8 (11.76)

4 (13.33)

1

3 (15)

1

1 (10)

1

0 (0)

1

 Myocardial damage

18 (26.47)

7 (23.33)

0.743

5 (25)

0.895

2 (20)

0.96

1 (14.29)

0.803

 Abnormal blood gas (hypoxemia, hypokalemia, etc.)

2 (2.94)

1 (3.33)

1

0 (0)

1

1 (10)

0.341

2 (28.57)

0.041

 Central nervous system infection

1 (1.47)

1 (3.33)

0.521

0 (0)

1

1 (10)

0.241

0 (0)

1

Underlying conditions

 Any condition (≥1 condition)

8 (11.76)

4 (13.33)

1

3 (15)

1

1 (10)

1

1 (14.29)

1

 Respiratory disease (asthma, congenital malformation etc.)

2 (2.94)

2 (6.67)

0.76

1 (5)

0.543

1 (10)

0.341

0 (0)

1

 Neurological Disease (epilepsy)

2 (2.94)

0 (0)

1

0 (0)

1

0 (0)

1

0 (0)

1

 Congenital heart disease

0 (0)

2 (6.67)

0.092

2 (10)

0.05

0 (0)

–

0 (0)

–

Disease severity parameters

 Severe CAPb

49 (72.06)

19 (63.33)

0.388

10 (50)

0.065

9 (90)

0.409

6 (85.71)

0.742

 PICU admission

0 (0)

0 (0)

–

0 (0)

–

0 (0)

–

0 (0)

–

 Noninvasive positive pressure ventilation

4 (5.88)

2 (6.67)

1

1 (5)

1

1 (10)

0.506

0 (0)

1

 Invasive mechanical ventilation

0 (0)

0 (0)

–

0 (0)

–

0 (0)

–

0 (0)

–

 Length of stay, median(IQR) (d)

13 (5)

14 (6)

0.177

14.5 (6)

0.163

13.5 (7)

0.599

11 (3)

0.319

  1. Data are presented as No. (%) unless otherwise indicated
  2. Mp Mycoplasma pneumoniae, Mp-Vir Mp-virus co-detection, Mp-HRV Mp-HRV co-detection, Mp-Bac Mp-bacteria co-detection, IQR interquartile range
  3. aAll cases of pulmonary atelectasis are single lobar; All cases of liver dysfunction, myocardial damage and abnormal blood gas are mild;
  4. bThe diagnosis criteria of severe CAP are in accordance with the Chinese Medical Association Guidelines for the management of community-acquired pneumonia in children (revised 2013) (Chin J Pediatr. 2013; 51(11):856–62)
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us